Datametrex AI Limited
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Datametrex AI Limited engages in the collection, analysis, and presentation of structured and unstructured data using machine learning and artificial intelligence technologies. The company operates through AI and Technology and Health Care segments, providing cybersecurity solutions including Nexology with NexaSecurity, a social media discovery and monitoring platform, and NexaSMART for generating reports; big data, artificial intelligence, and system integration services; hardware equipment sales; concierge medical and telemedicine services; and operation of medical clinics such as Imagine Health Centres offering family medicine, walk-in care, specialist services, IV therapy, Botox, and laser treatments. Founded in 2011 and headquartered in Toronto, Ontario, Canada, Datametrex maintains operations in Canada, Korea through its wholly-owned subsidiary Datametrex Korea, and additional locations in Vancouver, Seoul, Berlin, and Montreal, targeting government, corporate, financial, public sector, and healthcare customers. Recent developments include securing approximately CAD 650,000 in purchase orders in November 2025 through Datametrex Korea, advancing its land-and-expand strategy in IT infrastructure; closing financings in November 2025 raising CAD 5.13 million via common shares and subscription receipts; signing a letter of intent in September 2025 to acquire Yuzu payment processing solution from FirstPayment Inc.; announcing a new Edmonton South location for Imagine Health and addition of new physicians accepting patients in Calgary and Edmonton; appointing Enrico Moretti to its board of directors in October 2025; and outlining a strategic plan in February 2025 to focus on healthcare and AI through clinic expansions via mergers and acquisitions, wind-down of non-core businesses like pharmacy and mobile gaming, and a planned corporate restructuring to split into separate healthcare and AI entities.
Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Datametrex Announces Rebranding of Paymetrex to QuantIP Licensing Corp.
Datametrex Announces Enterprise Software Automation Contracts
Datametrex Secures New Nutanix Infrastructure Contracts as Enterprise Data Centre Modernization Accelerates
Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification Review
Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Datametrex Enters Strategic Agreement with Hilco Global to Advance Patent Monetization
Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program
Datametrex Receives $1M Order from Fortune 500 Client
Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Paymetrex Secures First U.S. License Payment
Datametrex Expands Business In Data Centres
Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio
Datametrex Announces Participation in AlphaNorth Capital Event
Datametrex Secures Approximately $400,000 in New Purchase Orders
Paymetrex and AnywhereCommerce Solidify Relationship
DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition